Toppenberg Alexandra G L, Nijboer Thomas S, van der Laan Wisse G W J, Wedman Jan, Schwandt Leonora Q, Plaat Robert E, Witjes Max J H, Wegner Inge, Halmos Gyorgy B
Department of Ear Nose Throat Surgery, University Medical Centre Groningen, 9713 GZ Groningen, The Netherlands.
Department of Otorhinolaryngology-Head and Neck Surgery, Medical Center Leeuwarden, 8934 AD Leeuwarden, The Netherlands.
Cancers (Basel). 2024 Apr 11;16(8):1458. doi: 10.3390/cancers16081458.
Transoral Robotic Surgery (TORS) is utilized for treating various malignancies, such as early-stage oropharyngeal cancer and lymph node metastasis of an unknown primary tumor (CUP), and also benign conditions, like obstructive sleep apnea (OSA) and chronic lingual tonsillitis. However, the success and failure of TORS have not been analyzed to date. In this retrospective observational multicenter cohort study, we evaluated patients treated with TORS using the da Vinci surgical system. Success criteria were defined as identification of the primary tumor for CUP, >2 mm resection margin for malignant conditions, and improvement on respiratory polygraphy and tonsillitis complaints for benign conditions. A total of 220 interventions in 211 patients were included. We identified predictors of success, such as low comorbidity status ACE-27, positive P16 status, and lower age for CUP, and female gender and OSA severity for benign conditions. For other malignancies, no predictors for success were found. Predictors of failure based on postoperative complications included high comorbidity scores (ASA) and anticoagulant use, and for postoperative pain, younger age and female gender were identified. This study provides valuable insights into the outcomes and predictors of success and failure in TORS procedures across various conditions and may also help in patient selection and counseling.
经口机器人手术(TORS)用于治疗各种恶性肿瘤,如早期口咽癌和原发灶不明的肿瘤(CUP)的淋巴结转移,也用于治疗良性疾病,如阻塞性睡眠呼吸暂停(OSA)和慢性舌扁桃体炎。然而,迄今为止尚未对TORS的成败进行分析。在这项回顾性观察性多中心队列研究中,我们评估了使用达芬奇手术系统接受TORS治疗的患者。成功标准定义为:对于CUP患者,确定原发肿瘤;对于恶性疾病患者,切缘>2mm;对于良性疾病患者,呼吸多导睡眠图改善且扁桃体炎症状减轻。共纳入211例患者的220次干预治疗。我们确定了成功的预测因素,如CUP患者合并症状态低(ACE-27)、P16状态阳性、年龄较小,以及良性疾病患者的女性性别和OSA严重程度。对于其他恶性肿瘤,未发现成功的预测因素。基于术后并发症的失败预测因素包括合并症评分高(ASA)和使用抗凝剂,对于术后疼痛,确定为年龄较小和女性性别。本研究为不同情况下TORS手术的结果以及成功和失败的预测因素提供了有价值的见解,也可能有助于患者选择和咨询。